Barclays PLC Increases Stock Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS)
Barclays PLC increased its holdings in Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) by 79.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,542 shares of the company’s stock after buying an additional 47,528 shares during the period. Barclays PLC’s holdings in […]
Barclays PLC increased its holdings in Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) by 79.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,542 shares of the company’s stock after buying an additional 47,528 shares during the period. Barclays PLC’s holdings in […]
